Aquablation therapy is a minimally invasive benign prostatic hyperplasia (BPH) surgical treatment option that is changing the tradeoff between BPH symptom relief and side effects. Learn more about this new BPH treatment and our unique approach:
What is Aquablation therapy?
Aquablation therapy is a minimally invasive, heat-free surgical technique to treat lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
How does Aquablation therapy work?
Aquablation therapy is delivered by the AquaBeam Robotic System, the world’s first commercially available autonomous tissue removal robot for the treatment of LUTS due to BPH. Aquablation therapy combines multi-dimensional imaging and autonomous robotics to deliver a heat-free waterjet to remove the enlarged prostate tissue with less risk of side effects that impact the quality of life than the surgical gold-standard TURP.
Who is an appropriate candidate for Aquablation therapy?
Aquablation therapy has been proven as a safe and effective treatment for BPH patients suffering from urinary symptoms. You should consult with your urologist to review all your options for your condition.
What happens during an Aquablation treatment?
Aquablation therapy is performed in the operating room, while the patient is either under spinal or general anesthesia. During the procedure, the urologist will use multi-dimensional imaging to identify the exact treatment plan based on the patient’s specific anatomy. Next, the AquaBeam Robotic System autonomously executes the treatment plan, removing the excess prostate tissue with a heat-free waterjet, eliminating the possibility of complications arising from thermal injury. The procedure takes less than an hour, and typically involves an overnight stay.
What happens immediately after the Aquablation therapy?
Patients may go home with a urinary catheter. For a few days, the patient may experience a slight burning during urination as well as rectal soreness. This can be managed with mild pain medication. Patients can resume their normal activities at the discretion of their physician.
What are your clinical results?
Backed by a global clinical trial, Aquablation therapy has demonstrated a significant reduction in sexual side effects when compared to transurethral resection of the prostate (TURP), the surgical gold standard. See clinical data.
What are the risks associated with Aquablation therapy?
The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. For more information about potential side effects and risks associated with Aquablation therapy, speak with your urologist or surgeon.